SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-020555
Filing Date
2018-04-13
Accepted
2018-04-13 18:03:52
Documents
1
Period of Report
2018-04-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv491089_4.html 4  
1 OWNERSHIP DOCUMENT tv491089_4.xml 4 8532
  Complete submission text file 0001144204-18-020555.txt   10021
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
CAPITELLI SARA B (Reporting) CIK: 0001509032 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 18755203